Related references
Note: Only part of the references are listed.Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
L. Cao et al.
ONCOGENE (2012)
Formation of Invadopodia-like Structures by Synovial Cells Promotes Cartilage Breakdown in Collagen-Induced Arthritis Involvement of the Protein Tyrosine Kinase Src
Annie Lauzier et al.
ARTHRITIS AND RHEUMATISM (2011)
Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
Keunhee Oh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease
Luca Elli et al.
LABORATORY INVESTIGATION (2011)
Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
Kapil Mehta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington's disease
Stephen J. McConoughey et al.
EMBO MOLECULAR MEDICINE (2010)
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
Beatrix Bartok et al.
IMMUNOLOGICAL REVIEWS (2010)
Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?
Linghong Huang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
Anupam Kumar et al.
PLOS ONE (2010)
Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin
J. Forsprecher et al.
AMINO ACIDS (2009)
Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis
A. Orlandi et al.
AMINO ACIDS (2009)
Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix
Roberto Buccione et al.
CANCER AND METASTASIS REVIEWS (2009)
Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases
G. De Vivo et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270
Balik Dzhambazov et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis A reflection of the involvement of transglutaminase in coeliac disease
Pal Stenberg et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Increased TG2 Expression Can Result in Induction of Transforming Growth Factor β1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide
Dilek Telci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion
Michelle J. Kean et al.
JOURNAL OF CELL SCIENCE (2009)
Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration
Nasim Shweke et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Tissue transglutaminase: A novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases
Micha M. M. Wilhelmus et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
TGF-β induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways
Shyamali Mandal et al.
EXPERIMENTAL CELL RESEARCH (2008)
The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis
Erika H. Noss et al.
IMMUNOLOGICAL REVIEWS (2008)
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and β1 integrin co-signaling
Dilek Telci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transglutaminase 2 undergoes a large conformational change upon activation
Daniel M. Pinkas et al.
PLOS BIOLOGY (2007)
Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease
Tim S. Johnson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor α-induced increases in tumor necrosis factor-α converting enzyme/ADAM17 expression by synovial cells
Martine Charbonneau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Polly R. Pine et al.
CLINICAL IMMUNOLOGY (2007)
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy
L. Yuan et al.
ONCOGENE (2007)
Transglutaminase 2 in neurodegenerative disorders
Qingmin Ruan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Quantitative image analysis of immunohistochemical stains using a CMYK color model
Nhu-An Pham et al.
DIAGNOSTIC PATHOLOGY (2007)
The matrix corroded: podosomes and invadopodia in extracellular matrix degradation
Stefan Linder
TRENDS IN CELL BIOLOGY (2007)
Actin dynamics at sites of extracellular matrix degradation
Massimiliano Baldassarre et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2006)
Transglutaminase 2 in inflammation
Soo-Youl Kim
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: Defining the stages of invadopodia formation and function
VV Artym et al.
CANCER RESEARCH (2006)
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
L Yuan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Functional imaging of pericellular proteolysis in cancer cell invasion
K Wolf et al.
BIOCHIMIE (2005)
CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients
R García-Vicuña et al.
ARTHRITIS AND RHEUMATISM (2004)
Tissue transglutaminase has intrinsic kinase activity - Identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase
S Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis
EAM Verderio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A novel function of tissue-type transglutaminase: protein disulphide isomerase
G Hasegawa et al.
BIOCHEMICAL JOURNAL (2003)
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis
H Nakahara et al.
ARTHRITIS AND RHEUMATISM (2003)
Tissue transglutaminase-induced aggregation of α-synuclein:: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies
E Junn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage
BT Summey et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2002)
Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin
SS Akimov et al.
BLOOD (2001)
Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa
K Johnson et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin
SS Akimov et al.
JOURNAL OF CELL BIOLOGY (2000)
Fibronectin fragments and their role in inflammatory arthritis
ML Barilla et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
Share Paper
